Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Wenzel

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Analytics of Functional Autoantibodies in Patients with Chagas DiseaseGerd Wallukat, Katrin Wenzel, Ingolf Schimke
Cardiovascular Drugs and Therapy|March 19, 2019
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling-Additional Information About TLR9 InvolvementAnnekathrin Haberland, Johannes Müller, Katrin Wenzel
Analytical and Bioanalytical Chemistry|June 28, 2018
Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors-a requisite for correct data evaluationAnnekathrin Haberland, Johannes Müller, Gerd Wallukat, et al.
Journal of Cardiac Surgery|November 25, 2005
Gene expression analysis of human tissue from patients with cardiomyopathies: a new tool for guiding therapies in the future?Andreas Perrot, Zhyldyz Kabaeva, Katrin Wenzel, et al.
Biochimica Et Biophysica Acta|February 6, 2004
Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitroReinhard Zeisig, Renate Stahn, Katrin Wenzel, et al.
Plos One|February 10, 2018
Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technologyKatrin Wenzel, Sarah Schulze-Rothe, Johannes Müller, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Determination of Agonistically Acting Autoantibodies to the Adrenergic Beta-1 Receptor by Cellular BioassayHanna Davideit, Annekathrin Haberland, Sabine Bartel, et al.
Heliyon|August 11, 2017
Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathyKatrin Wenzel, Sarah Schulze-Rothe, Annekathrin Haberland, et al.
ESC Heart Failure|March 27, 2020
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomesSabine Werner, Gerd Wallukat, Niels-Peter Becker, et al.
Plos One|July 6, 2019
Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathyGerhard Wess, Gerd Wallukat, Anna Fritscher, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Analytics of Functional Autoantibodies in Patients with Chagas DiseaseGerd Wallukat, Katrin Wenzel, Ingolf Schimke
Cardiovascular Drugs and Therapy|March 19, 2019
Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling-Additional Information About TLR9 InvolvementAnnekathrin Haberland, Johannes Müller, Katrin Wenzel
Analytical and Bioanalytical Chemistry|June 28, 2018
Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors-a requisite for correct data evaluationAnnekathrin Haberland, Johannes Müller, Gerd Wallukat, et al.
Journal of Cardiac Surgery|November 25, 2005
Gene expression analysis of human tissue from patients with cardiomyopathies: a new tool for guiding therapies in the future?Andreas Perrot, Zhyldyz Kabaeva, Katrin Wenzel, et al.
Biochimica Et Biophysica Acta|February 6, 2004
Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitroReinhard Zeisig, Renate Stahn, Katrin Wenzel, et al.
Plos One|February 10, 2018
Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technologyKatrin Wenzel, Sarah Schulze-Rothe, Johannes Müller, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Determination of Agonistically Acting Autoantibodies to the Adrenergic Beta-1 Receptor by Cellular BioassayHanna Davideit, Annekathrin Haberland, Sabine Bartel, et al.
Heliyon|August 11, 2017
Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathyKatrin Wenzel, Sarah Schulze-Rothe, Annekathrin Haberland, et al.
ESC Heart Failure|March 27, 2020
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomesSabine Werner, Gerd Wallukat, Niels-Peter Becker, et al.
Plos One|July 6, 2019
Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathyGerhard Wess, Gerd Wallukat, Anna Fritscher, et al.
Pageof 4